The National Cancer Institute awards a $12 million grant to the University of Wisconsin and Frontier Science Foundation
Frontier Science Foundation, in partnership with the University of Wisconsin-Madison (UW), has been awarded a large five-year project from the National Cancer Institute (NCI) as a Data Management, Auditing, and Coordinating Center (DMACC) for the Cancer Prevention Clinical Trials Network (CP-CTNet) in the United States. KyungMann Kim, PhD, professor, Department of Biostatistics and Medical Informatics at the University of Wisconsin School of Medicine and Public Health, will lead the DMACC in the UW Department of Biostatistics and Medical Informatics. Frontier Science Foundation, headquartered in Amherst, New York, brings its decades of cancer research experience and its exceptional data management expertise into this large US-based initiative to provide data management and research support.
The Cancer Prevention Clinical Trials Network performs early phase clinical trials to assess the safety, tolerability, and cancer preventive potential of agents and interventions of varying classes, many of which target molecules or processes known to be important during carcinogenesis. The goal for the Cancer Prevention Clinical Trials Network is to identify safe and effective preventive interventions in order to advance further clinical development for cancer prevention. Having a major role in the DMACC for the CP-CTNet, Frontier Science will lead the centralized data management and reporting unit and have a significant role in the auditing activities.
“This is an exciting opportunity for Frontier Science to bring our experience and expertise in data management innovations to one of the nation’s premier programs in cancer prevention,” says Sue Siminski, Chief Executive Officer of Frontier Science Foundation and Director of the Data Management and Reporting Unit for this new initiative. “We look forward to working with the National Cancer Institute and the participating centers in advancing the network’s goal to identify safe and effective cancer prevention interventions.”
Frontier Science Foundation is a not-for-profit organization that has gained an international reputation for its capabilities in data management and statistics. The foundation’s mission is to advance the application of statistical science and practice and data management techniques in science, health care and education in diseases such as cancer and HIV/AIDS research, among others. Frontier Science collaborates with research networks, academic institutions, pharmaceutical companies, and individual investigators in the design, conduct, and execution of clinical trials and observational studies conducted around the world. Founded in 1975, Frontier Science currently employs 250 biostatisticians, software engineers, data managers and research support staff in three locations in the United States, with international affiliate offices in Scotland, Greece and Norway.